Quantum-Cascade Laser Biosensor for Protein Secondary Structure Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for secondary structure analysis of proteins in complex fluids like serum, blood plasma, or cerebrospinal fluid require prior isolation and concentration, which can alter protein structures and lack direct information about secondary structures, limiting their ability to detect specific conformations relevant to diseases such as Alzheimer's.

Innovation Solution

A tunable quantum-cascade laser-based infrared detection system using a germanium internal reflection element with antibodies immobilized via silane or thiol linkers, allowing for direct analysis of secondary structures in complex fluids without prior isolation, enabling the detection of specific protein conformations associated with disease progression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If conventional methods (ELISA, SPR, FTIR) are used for protein analysis, then quantitative detection or secondary structure information can be obtained, but direct information about specific secondary structures in complex fluids is not provided and prior isolation is required

Engineering Contradiction:
Improvesecondary structure informationVSAvoidisolation procedure complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The patent merges the specific binding capability of antibodies with the secondary structure detection capability of infrared spectroscopy in a single integrated system. The antibody-immobilized sensor surface captures target proteins from complex fluids, and the infrared detection system simultaneously provides quantitative and conformational information, eliminating the need for separate isolation steps

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The biosensor system performs multiple functions simultaneously: it detects the presence and concentration of target proteins through antibody binding, determines secondary structure composition through infrared spectroscopy, and provides both qualitative and quantitative information from a single measurement without requiring different preparation procedures

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If prior isolation and concentration of proteins is performed, then secondary structure analysis can be conducted, but protein structures may be altered and measuring time increases

Engineering Contradiction:
Improvesecondary structure analysis accuracyVSAvoidmeasuring time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The antibody is pre-immobilized on the sensor surface in advance, creating a ready-to-use capture surface. When the complex fluid is introduced, the target protein is immediately captured and analyzed without requiring time-consuming isolation or concentration steps, thus maintaining native structure and reducing measurement time

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If antibodies are immobilized on sensor surfaces via conventional methods, then protein detection is enabled, but the immobilization process may influence and change the secondary structure of the analyte

Engineering Contradiction:
Improvedetection capabilityVSAvoidprotein secondary structure
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent uses a carefully designed immobilization chemistry with controlled linker lengths and densities as an intermediary between the sensor surface and the target protein. This intermediary layer minimizes direct surface-protein interactions that could induce conformational changes, allowing the protein to maintain its native secondary structure while still enabling specific detection

Inventive Principle:
Principle #24Intermediary (Mediator)

4Measurement precision

If conventional infrared sources are used, then secondary structure analysis is possible, but sensitivity is insufficient for detecting low-concentration proteins in complex fluids

Engineering Contradiction:
Improvedetection sensitivityVSAvoidlight source intensity
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The patent employs a quantum cascade laser that operates in the mid-infrared region, specifically targeting the amide I band frequency range (1600-1700 cm⁻¹) where protein secondary structure information is encoded. This parameter change in the light source wavelength and intensity provides the sensitivity needed to detect low-concentration proteins while maintaining specificity for secondary structure analysis

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides enhanced sensitivity and specificity for detecting protein secondary structures in complex fluids, enabling earlier diagnosis of diseases like Alzheimer's by analyzing the amide I band, with a significantly reduced measuring time and a compact, clinically suitable instrument.

Implementation Method 1

a tunable quantum-cascade laser as the IR source

Methodology Applied
Scientific EffectLaser: Laser

Implementation Method 2

by vibrational spectroscopic methods utilizing a quantum-cascade laser

Methodology Applied
Scientific EffectVibrational spectroscopy: Absorption Spectroscopy

Implementation Method 3

an IR cell with an infrared sensor element that comprises a germanium internal reflection element

Methodology Applied
Scientific EffectTotal internal reflection: Total Internal Reflection

Implementation Method 4

at least one receptor for the biomarker protein being an antibody capable of specific and conformationally independent binding to the candidate biomarker protein

Methodology Applied
Scientific EffectMolecular recognition: Adsorption

Implementation Method 5

being directly grafted to at least one surface of said internal germanium reflection element by silanization with short silane linkers or by thiolation with short thiol linkers

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 6

A difference-spectrum between the unbound and antibody-bound protein of interest is performed by which the much larger background absorbance is cancelled

Methodology Applied
Scientific EffectSpectroscopic subtraction: Absorption Spectroscopy

Data Source

PatentEP3631446B1Biosensor for conformation and secondary structure analysis
Publication Date: 2024.04.17 BETASENSE GMBH
  • EP3631446B1 patent drawingFigure 1A~1C
  • EP3631446B1 patent drawingFigure 2
  • EP3631446B1 patent drawingFigure 3A~3D

AI summary

The invention provides an infrared detection system for conformation and secondary structure analysis, notably for the direct non-invasive qualitative secondary structure analysis of a single selected protein within a complex mixture, as e.g. a body fluid, by vibrational spectroscopic methods utilizing a quantum- cascade laser. For the analysis it is not required that the selected substance be isolated, concentrated, or pretreated by a special preparative procedure. A difference-spectrum between the unbound and antibody-bound protein of interest is performed by which the much larger background absorbance is cancelled. The presented quantum- cascade laser set-up provides sufficient S/N and stability to subtract the several orders of magnitude larger background absorbance.